$72.40 -0.39 (%) Novartis Shs Sponsored American Deposit Receipt Repr 1 Sh - New York Stock Exchange, Inc.

Jan. 13, 2017 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Trump + Stocks: The Week In Review

    TalkMarkets | Jan. 13, 2017 | 19:44PM EST
  2. Ionis Pharma Stock Bounds On $100 Million Novartis Investment

    Investors Business Daily | Jan. 6, 2017 | 15:56PM EST
  3. Mylan, Novartis, Hikma Take On GSK In Generic Asthma Battle

    Investors Business Daily | Jan. 5, 2017 | 13:31PM EST
  4. A Secure And Growing Dividend In Healthcare

    TalkMarkets | Jan. 4, 2017 | 16:56PM EST
  5. Lilly Nears FDA Nod On Arthritis Drug, But Chemo Med Stuck In Court

    Investors Business Daily | Jan. 4, 2017 | 13:26PM EST
  6. Amgen Plans Robust 2017 In Alzheimer's, Migraines, Oncology: CEO Exclusive

    Investors Business Daily | Jan. 2, 2017 | 08:15AM EST
  7. J&J Back In Talks With Actelion, Teva Settles Corruption Probe

    TalkMarkets | Dec. 23, 2016 | 13:37PM EST
  8. Sensex Stays in the Red; Metal Stocks Witness Maximum Selling Pressure

    TalkMarkets | Dec. 22, 2016 | 03:40AM EST
  9. Conatus Pharma Skyrockets On Novartis NASH Liver Drug Licensing Deal

    Investors Business Daily | Dec. 19, 2016 | 17:52PM EST
  10. Jefferies Says Sell Merck, Buy Bristol-Myers Heading Into New Year

    TalkMarkets | Dec. 19, 2016 | 12:48PM EST
  11. Incyte Could Step Onto Auction Block With Strong Jakafi Sales: RBC

    Investors Business Daily | Dec. 19, 2016 | 11:58AM EST
  12. These 8 Top Dividend Stocks Are Also ADRs - Check Them Out

    TalkMarkets | Dec. 13, 2016 | 08:00AM EST
  13. Biotechs Mixed Hurt By Alexion And Ophthotech

    TalkMarkets | Dec. 12, 2016 | 23:03PM EST
  14. Regeneron Spikes On Blurry-Eye Win Vs. Failed Ophthotech Drug

    Investors Business Daily | Dec. 12, 2016 | 13:34PM EST
  15. Johnson & Johnson Boosted By Barron's Call For Rally

    TalkMarkets | Dec. 12, 2016 | 13:00PM EST
  16. Week In Review: JHL Biotech Signs $257 Million Biosimilar Deal With Sanofi

    TalkMarkets | Dec. 10, 2016 | 12:44PM EST
  17. Mylan Slumps After Disclosing Plans To Cut Workforce In Restructuring

    TalkMarkets | Dec. 7, 2016 | 13:12PM EST
  18. Sanofi May Battle Johnson & Johnson For European Biotech Actelion

    Investors Business Daily | Dec. 6, 2016 | 12:01PM EST
  19. Lung Disease Stocks Advance After Actelion Approached By J&J

    TalkMarkets | Nov. 25, 2016 | 17:04PM EST
  20. Calithera In Focus, Part 2 - Upcoming Catalysts In TNBC And RCC

    TalkMarkets | Nov. 23, 2016 | 11:45AM EST
  21. Batten Down The Bonds

    TalkMarkets | Nov. 14, 2016 | 23:38PM EST
  22. Markets In Turmoil: Global Bond Bloodbath, Currency Rout Accelerates As Stocks Erase Early Gains

    TalkMarkets | Nov. 14, 2016 | 06:53AM EST
  23. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets | Nov. 9, 2016 | 12:48PM EST
  24. IPO Preview: Ra Pharmaceuticals

    TalkMarkets | Oct. 26, 2016 | 01:02AM EST
  25. Apple Bites - Financial Review

    TalkMarkets | Oct. 25, 2016 | 23:03PM EST
  26. Novartis Tops Q3 Earnings, Misses Sales Estimates

    TalkMarkets | Oct. 25, 2016 | 12:47PM EST
  27. Phase 2b Data Continues To Impress From HedgePath Pharma

    TalkMarkets | Oct. 21, 2016 | 04:18AM EST
  28. 7 Drug Stocks To Consider As Biosimilars Pick Up Pace

    TalkMarkets | Oct. 20, 2016 | 13:53PM EST
  29. Bristol-Myers Falls As Merck Upstages With New Lung Cancer Data

    TalkMarkets | Oct. 10, 2016 | 18:35PM EST
  30. Week In Review: Teva Pays $160 Million For US/Canada Rights To Celltrion Biosimilars

    TalkMarkets | Oct. 8, 2016 | 13:30PM EST
  31. 10 Stocks John Rogers Keeps Buying

    GuruFocus | Sep. 27, 2016 | 16:59PM EST
  32. Kite Pharma Soars As Cancer Drug Trial Supportive Of FDA Approval

    IBD | Sep. 27, 2016 | 15:20PM EST
  33. Kite Pharma Jumps After CAR-T Cancer Drug Success

    TalkMarkets | Sep. 26, 2016 | 22:04PM EST
  34. The Internet Of Medical Things: 6 Stocks In Focus

    TalkMarkets | Sep. 26, 2016 | 12:20PM EST
  35. Apple, Facebook, Alphabet, Amazon, Ford, McDonald's Headline Busy Week

    Investors Business Daily | Jul. 29, 2016 | 11:13AM EST
  36. Week In Review: Stock Breakouts, Netflix Subs Snub, Tesla's Plan, M&A News

    Investors Business Daily | Jul. 22, 2016 | 11:25AM EST
  37. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 09:44AM EST
  38. Roche Holdings Definitely Not a Lumbering Giant

    GuruFocus | Jul. 11, 2016 | 12:24PM EST
  39. Valeant's Share Price Continues to Decline

    GuruFocus | Feb. 5, 2016 | 15:10PM EST
  40. Earnings Recap For January 27

    Benzinga | Jan. 27, 2016 | 17:17PM EST
  41. 10 Fund Managers Are Totally Wrong on GlaxoSmithKline

    GuruFocus | Jan. 26, 2016 | 14:59PM EST
  42. Guru Stocks at 52-Week Lows

    GuruFocus | Jan. 26, 2016 | 12:26PM EST
  43. Juno Buyout Puts Single-Cell Sequencing In Spotlight

    IBD | Jan. 15, 2016 | 17:30PM EST
  44. Berkshire Hathaway, Wells Fargo, China Mobile, Novartis, Bank of America Reach 52-Week Lows

    GuruFocus | Jan. 11, 2016 | 13:36PM EST
  45. Novartis Announces Collaboration and Licensing Agreement with Surface Oncology

    Benzinga | Jan. 11, 2016 | 04:19AM EST
  46. Mylan, Momenta Team Up To Develop Biosimilar Drugs

    IBD | Jan. 8, 2016 | 15:34PM EST
  47. 3 Potential Blockbuster Drugs Launching in 2016

    IBD | Jan. 6, 2016 | 09:42AM EST
  48. Berkshire Hathaway, China Mobile, Novartis, Oracle, PetroChina Near 52-Week Lows

    GuruFocus | Jan. 4, 2016 | 12:52PM EST
  49. Big Biotech Amgen Facing Pivotal Year In 2016

    IBD | Dec. 17, 2015 | 17:08PM EST
  50. Novartis Announces New CTL019 Study Data Demonstrating Overall Response in Adults with Certain Types of Lymphoma at #ASH2015

    Benzinga | Dec. 6, 2015 | 08:43AM EST
Trading Center